79032245 - PENUMBRA IS BRAIN

Information

• Trademark
• 79032245

• Source

• Serial Number

  79032245

• Registration Number

  3580586

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  July 25, 2006
  18 years ago

• Registration Date

  February 24, 2009
  15 years ago

• Transaction Date

  April 14, 2017
  7 years ago

• Status Date

  July 25, 2016
  8 years ago

• Published for Opposition Date

  December 18, 2007
  17 years ago

• Location Date

  February 24, 2009
  15 years ago

• Status Code

  404

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  SOMERVILLE, ARETHA CHA

• Law Office Assigned Location Code

  L70

• Owners

  • PAION DEUTSCHLAND GMBH

Case File Statements

• CC0000: Color is not claimed as a feature of the mark.
• GS0011: Biochemical preparations for scientific purposes; reagents for research
• GS0051: Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment and diagnosis of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutriceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; blood cloning test kits comprised of medical diagnostic reagents; medical and clinical diagnostic reagents for clinical or medical laboratory use; Pharmaceutical preparations, namely, thrombolytic, fibrinolytic anti-coagulative, antithrombotical or neuroprotective substances for the treatment of blood clotting, cell protection and cell regeneration; products from biotechnological methods, namely, proteins for therapeutic and diagnostic use in the treatment and diagnosis of blood clotting disorders
• GS0101: Laboratory and analysis apparatus for medical, pharmaceutical and laboratory tests; medical devices, namely, coated catheters, medical stents, surgical implants comprising artificial materials; membranes intended for medical use, namely, filters for dialysis, hemofiltration
• GS0411: Educational services, namely, providing seminars, informational events and/or workshops in the field of biotechnology, pharmacology, biochemistry, molecular biology, medical procedures, product research and development of medical devices and pharmaceutical preparations, research procedures, protein design diagnostics, molecular diagnostics, proteogenomic profiling, gendiagnostics
• GS0421: Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; licensing of intellectual property; services of a biotechnological laboratory, namely, conducting lab research for others in the field of drug research and development; pharmaceutical consulting, namely, providing pharmaceutical advice to others regarding governmental regulatory laws and practices, performing pre-clinical studies, quality control; preparation of expert opinions in the field of chemical engineering, biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry, product research and development of medical devices and pharmaceutical preparations, and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the area of gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins; diagnostic services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries; performance of pre-clinical studies, namely, conducting and managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products; bio-chemical and biotechnological research and development for others, namely, bio-technological research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment, scientific research on and development of medical diagnostic equipment and pharmaceutical preparations and products for the treatment of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others, namely, prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA-microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment

Case File Event Statements

• 4/14/2017 - 7 years ago

  39 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT

• 2/24/2017 - 7 years ago

  38 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED Type: DENC

• 2/24/2017 - 7 years ago

  37 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH

• 5/27/2016 - 8 years ago

  36 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS

• 5/27/2016 - 8 years ago

  35 - INVALIDATION PROCESSED Type: INPC

• 5/25/2016 - 8 years ago

  34 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR

• 9/25/2015 - 9 years ago

  33 - CANCELLED SECTION 71 Type: C71T

• 12/13/2013 - 11 years ago

  32 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 1/11/2013 - 11 years ago

  31 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 5/29/2009 - 15 years ago

  30 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 5/29/2009 - 15 years ago

  29 - FINAL DISPOSITION PROCESSED Type: FIMP

• 5/24/2009 - 15 years ago

  28 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 2/24/2009 - 15 years ago

  27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 1/15/2009 - 15 years ago

  26 - TTAB RELEASE CASE TO TRADEMARKS Type: TMBN

• 1/15/2009 - 15 years ago

  25 - OPPOSITION TERMINATED NO. 999999 Type: OP.T

• 1/15/2009 - 15 years ago

  24 - OPPOSITION DISMISSED NO. 999999 Type: OP.D

• 5/23/2008 - 16 years ago

  23 - REFUSAL PROCESSED BY IB Type: RFNP

• 4/18/2008 - 16 years ago

  22 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I

• 4/17/2008 - 16 years ago

  21 - OPPOSITION NOTICE (IB REFUSAL) SENT TO IB Type: OPNS

• 4/17/2008 - 16 years ago

  20 - OPPOSITION NOTICE (IB REFUSAL) CREATED Type: OPNC

• 12/20/2007 - 17 years ago

  19 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF

• 12/18/2007 - 17 years ago

  18 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/28/2007 - 17 years ago

  17 - NOTICE OF PUBLICATION Type: NPUB

• 11/14/2007 - 17 years ago

  16 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 11/14/2007 - 17 years ago

  15 - ASSIGNED TO LIE Type: ALIE

• 10/10/2007 - 17 years ago

  14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/27/2007 - 17 years ago

  13 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC

• 7/27/2007 - 17 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/26/2007 - 17 years ago

  11 - ASSIGNED TO LIE Type: ALIE

• 7/10/2007 - 17 years ago

  10 - PAPER RECEIVED Type: MAIL

• 6/12/2007 - 17 years ago

  9 - ASSIGNED TO EXAMINER Type: DOCK

• 2/1/2007 - 17 years ago

  8 - REFUSAL PROCESSED BY IB Type: RFNT

• 1/10/2007 - 17 years ago

  7 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 1/10/2007 - 17 years ago

  6 - REFUSAL PROCESSED BY MPU Type: RFRR

• 12/29/2006 - 17 years ago

  5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 12/28/2006 - 17 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/22/2006 - 18 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 12/22/2006 - 18 years ago

  2 - NEW APPLICATION ENTERED IN TRAM Type: NWAP

• 12/21/2006 - 18 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR